Category: News

CHEYENNE, Wyoming, Aug. 05, 2026 (GLOBE NEWSWIRE) — Next Technology Holding Inc. (“NXTT” or the “Company”) (NASDAQ: NXTT), a technology firm committed to delivering AI-enabled software development services and strategic Bitcoin acquisition, announced today that it will implement a reverse stock split of its issued and outstanding shares of common stock at a ratio of 100-for-1, effective at 12:01 a.m., Eastern Time on August 10, 2026. The reverse stock split will be effected simultaneously for all outstanding shares of the company’s common stock and will affect all of the Company’s stockholders uniformly.

Blueprint Gaming’s Top-Performing Branded Slot Expands to a Second Canadian Market

Blueprint Gaming's Top-Performing Branded Slot Expands to a Second Canadian Market

The chronic urticaria clinical trial analysis report delivers important insights into ongoing research of 30+ pipeline chronic urticaria drugs, clinical strategies, upcoming therapeutics, and commercial analysis.

The chronic urticaria clinical trial analysis report delivers important insights into ongoing research of 30+ pipeline chronic urticaria drugs, clinical strategies, upcoming therapeutics, and commercial analysis.

Common Stock Begins Trading on the Nasdaq Capital Market Under “QNME”

New toll-free multi-use path connects Windsor’s Great Lakes Waterfront Trail to Detroit’s Iron Belle Trail and Great Lakes Way, creating a unique active transportation link between Canada and the United States

New toll-free multi-use path connects Windsor's Great Lakes Waterfront Trail to Detroit's Iron Belle Trail and Great Lakes Way, creating a unique active transportation link between Canada and the United States

Following a challenge brought by Galderma Laboratories, L.P., BBB National Programs’ National Advertising Division found certain challenged claims made by Sanofi S.A. supported but recommended that Sanofi modify or discontinue other claims regarding long-lasting clearer skin, fast itch relief, and a prescriber-facing day-2 itch relief claim.

Following a challenge brought by Galderma Laboratories, L.P., BBB National Programs' National Advertising Division found certain challenged claims made by Sanofi S.A. supported but recommended that Sanofi modify or discontinue other claims regarding long-lasting clearer skin, fast itch relief, and a prescriber-facing day-2 itch relief claim.

MoneyPass Group began operating as an independent company following the close of a previously announced joint venture between Bridgeport Partners & Fiserv.

SOGECLAIR SIGNS AN AGREEMENT WITH AKKODIS TO DIVEST ITS ENGINEERING ACTIVITIES DEDICATED TO AIRBUS

SOGECLAIR SIGNE UN PROTOCOLE D’ACCORD AVEC AKKODIS EN VUE DE LA CESSION DE SES ACTIVITÉS D’INGÉNIERIE DÉDIÉES À AIRBUS

RALEIGH, N.C., Aug. 05, 2026 (GLOBE NEWSWIRE) — Martin Marietta Materials, Inc. (NYSE: MLM) (Martin Marietta or the Company), today announced that it has received all necessary regulatory approvals for its previously announced combination with Lhoist North America, Inc. (LNA). The transaction is now expected to close in the third quarter of 2026, subject to customary closing conditions.

New analysis also finds broad-based growth beyond high-volume plaintiffs, record design patent filings, continued concentration in the Eastern District of Texas, and more than $2.3 billion in 2025 patent damages

New analysis also finds broad-based growth beyond high-volume plaintiffs, record design patent filings, continued concentration in the Eastern District of Texas, and more than $2.3 billion in 2025 patent damages

New bipartisan legislation would advance standardized patient matching to reduce medical errors and improve patient safety nationwide.

New bipartisan legislation would advance standardized patient matching to reduce medical errors and improve patient safety nationwide.

CMiC and Dodge Construction Network survey highlights gaps in the usage in project controls capabilities despite increased technology investment

CMiC and Dodge Construction Network survey highlights gaps in the usage in project controls capabilities despite increased technology investment

PRESS INFORMATION
Heading: 1^st half 2026 revenues        Nanterre, August 5, 2026 (after trading)

INFORMATION PRESSE        Nanterre, le 5 août 2026 (après Bourse)
Rubrique : C.A. 1^er semestre 2026

In a new presentation, James Altucher explains the prediction behind the codename and how he believes everyday investors can position for it

In a new presentation, James Altucher explains the prediction behind the codename and how he believes everyday investors can position for it

Two newly published papers underscore the need for increased awareness, caregiver education, and preparedness to help ensure timely use of epinephrine during severe allergic reactions

Two newly published papers underscore the need for increased awareness, caregiver education, and preparedness to help ensure timely use of epinephrine during severe allergic reactions